reviewJAMAMar 17, 2025Closed access

Chronic Myeloid Leukemia

The University of Texas MD Anderson Cancer Center

PubMed
Indexed incrossrefpubmed

Abstract

Importance: Chronic myeloid leukemia (CML) has an annual incidence of 2 cases per 100 000 people and is newly diagnosed in approximately 9300 individuals per year in the US. Approximately 150 000 people in the US and 5 million worldwide have CML. Observations: Chronic myeloid leukemia is a myeloproliferative neoplasm characterized by the presence of the Philadelphia chromosome, which is defined by the BCR::ABL1 oncogene that develops after fusion of the ABL1 proto-oncogene to the constitutively active BCR gene. Approximately 90% of people with CML present with an indolent chronic phase of CML, defined as blasts of less than 10% in the blood or bone marrow, absence of extramedullary evidence of leukemia,…

Citation impact

74
total citations
FWCI
96.14
Percentile
100%
References
80
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Dasatinib
  • Nilotinib
  • Imatinib
  • Bosutinib
  • Philadelphia chromosome
  • Myeloid leukemia
  • Imatinib mesylate
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.